"Salmeterol Xinafoate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective ADRENERGIC BETA-2 RECEPTOR agonist that functions as a BRONCHODILATOR when administered by inhalation. It is used to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
| Descriptor ID |
D000068299
|
| MeSH Number(s) |
D02.033.100.291.057.750 D02.092.063.291.057.750 D02.092.471.683.061.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Salmeterol Xinafoate".
Below are MeSH descriptors whose meaning is more specific than "Salmeterol Xinafoate".
This graph shows the total number of publications written about "Salmeterol Xinafoate" by people in this website by year, and whether "Salmeterol Xinafoate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2011 | 0 | 2 | 2 |
| 2017 | 2 | 2 | 4 |
| 2018 | 1 | 2 | 3 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Salmeterol Xinafoate" by people in Profiles.
-
A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection. Mol Syst Biol. 2021 08; 17(8):e10239.
-
Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial. Respir Res. 2018 Dec 13; 19(1):251.
-
Double combination inhalers in COPD: How to get your head around this data. Respirology. 2018 12; 23(12):1088-1089.
-
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD. Pharmacol Res. 2018 07; 133:160-169.
-
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD. Eur Respir J. 2017 10; 50(4).
-
Application of a One-Dimensional Computational Model for the Prediction of Deposition from a Dry Powder Inhaler. J Aerosol Med Pulm Drug Deliv. 2017 Dec; 30(6):435-443.
-
Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study. BMC Pulm Med. 2017 Apr 28; 17(1):75.
-
IL-33/ST2 immune responses to respiratory bacteria in pediatric asthma. Sci Rep. 2017 03 06; 7:43426.
-
Effects of intranasal salmeterol and fluticasone given alone and in combination in persistent allergic rhinitis. Ann Allergy Asthma Immunol. 2012 Jan; 108(1):54-59.
-
Controversies regarding long-acting ß2-agonists. Curr Opin Allergy Clin Immunol. 2011 Aug; 11(4):345-54.